Summary: Ocular surface disease is one of the most frequent presentations to optometry practice. Whilst conventional therapies often focus on reducing patient symptomatology, novel therapeutics are being developed to target disease pathophysiology. This lecture will provide a contemporary update on the management of treatment of different types of ocular surface disease.
Learning Objective: To be knowledgeable of current and emerging approaches for treating ocular surface disease
If you are watching this for the first time and intend to claim the CPD time of 0.5hrs, please note completing and passing 3 out of the 5 optional MCQS will give you an additional 0.25 CPD hrs, making this WAVE On Demand worth 0.75T CPD Hrs.
If you are watching to recap as you have already seen this presentation at WAVE Live, you are very welcome to watch any WAVE Live presentation but will not be eligible for any CPD. ** If you are having issues viewing the video stream on this page, please contact admin@optometrywa.org & also try an alternative device / browser.
The GDPR does not specifically apply to Optometry Australia / Optometry WA as the latter does not have an establishment in the EU nor intentionally engage in targeted marketing to EU individuals specifically. In relation to the management of member data Optometry Australia's current Privacy Act is fully compliant with the respective GDPR data regulations.
We use cookies to ensure you get the best experience on our platform and by continuing to use this site you agree that we can save them on your device. For more information, please read our privacy policy.
Privacy Policy
